Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINTRAVENOUSGeneric

PALONOSETRON HYDROCHLORIDE

PALONOSETRON HYDROCHLORIDE

Standard Dose
EQ 0.25MG BASE/5ML (EQ 0.05MG BASE/ML)
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview PALONOSETRON HYDROCHLORIDE is listed in Drugs@FDA under application 208109 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient PALONOSETRON HYDROCHLORIDE Form and strength SOLUTION;INTRAVENOUS - EQ 0.25MG BASE/5ML (EQ 0.05MG BASE/ML) Sponsor FRESENIUS KABI USA Submission history Latest submission status date: 2018-12-06 00:00:00.

Structured Monograph

Clinical summary

Approval overview PALONOSETRON HYDROCHLORIDE is listed in Drugs@FDA under application 208109 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient PALONOSETRON HYDROCHLORIDE Form and strength SOLUTION;INTRAVENOUS - EQ 0.25MG BASE/5ML (EQ 0.05MG BASE/ML) Sponsor FRESENIUS KABI USA Submission history Latest submission status date: 2018-12-06 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.